Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences statistics
39 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (QoQ)
- 0.00%
- 0.50%
- Float
- 69M
- 49M
- Shares Held by Insiders
- 1.89%
- 11.7%
MarginsIndustry
- Pretax Margin
- -34.9%
- -11.6%
- EBITDA Margin
- 29.7%
- -27.7%
Returns on capitalIndustry
- Return on Assets (ROA)
- -30.3%
- -40.6%
Financial positionIndustry
- Current Ratio
- 0.09
- 3.30
- Quick Ratio
- 0.05
- 2.39
- Interest Coverage
- 0.57
- -6.35
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -12.2%
- 2.25%
- Revenue Growth (5Y CAGR)
- -11.7%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.78
- 0.40
- Inventory Turnover
- 0.69
- 2.73
- Revenue Per Employee
- $470.61K
- $429.29K
- Profits Per Employee
- -$182.52K
- -$689.41K
- Employee Count
- 33
- 74
Income statement (TTM)Industry
- Pretax Income
- -$5.43M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $2.81M
- $17.76M
- Net Cash Per Share
- $0.04
- $0.80
- Equity (Book Value)
- -$66.18M
- $53.89M
- Book Value Per Share
- -$0.94
- $1.50
- Tangible Book Value
- -$66.18M
- $27.13M
- Working Capital
- -$60.11M
- $79.99M
Cash flow (TTM)Industry
Taxes and interestIndustry
- Interest Expense
- $7.92M
- $2.90M
- Income Tax
- $598.00K
- $73.00K
Scores and fair valueIndustry
- Piotroski F-Score
- 5
- 4
- Beneish M-Score
- -4.00
- -2.63
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | EMMA | S&P 500 | Difference | EMMA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -26.4% | +0.6% | −27.0 pts | ||
| 3 months | +338.6% | +3.4% | +335.2 pts | ||
| Year to date | +284.6% | +13.3% | +271.3 pts | ||
| 1 year | +320.2% | +16.6% | +303.6 pts | ||
| 3 years | -64.2% | +86.4% | −150.6 pts | -29.0% | +23.1% |
| 5 years | -96.7% | +81.9% | −178.5 pts | -49.4% | +12.7% |
| 10 years | -99.9% | +318.9% | −418.8 pts | -50.2% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M EMMA shares were sold short on Oct 30, 2026, up 229.2% from the previous report. At recent volumes it would take 1.0 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 9,890 | +229.2% | 25,967 | 1.0 |
| Oct 15, 2026 | 3,004 | -78.4% | 19,959 | 1.0 |
| Sep 30, 2026 | 13,919 | -14.0% | 104,521 | 1.0 |
| Sep 15, 2026 | 16,177 | -24.9% | 81,012 | 1.0 |
| Aug 31, 2026 | 21,539 | +610.2% | 885,605 | 1.0 |
| Aug 14, 2026 | 3,033 | 0.0% | 115,575 | 1.0 |
| Jul 31, 2026 | 3,033 | 0.0% | 26,348 | 1.0 |
| Jul 15, 2026 | 3,033 | +85.7% | 65,515 | 1.0 |
| Jun 30, 2026 | 1,633 | 0.0% | 110,999 | 1.0 |
| Jun 15, 2026 | 1,633 | 0.0% | 139,760 | 1.0 |
| May 29, 2026 | 1,633 | 0.0% | 83,419 | 1.0 |
| May 15, 2026 | 1,633 | 0.0% | 138,199 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?